Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| TGFβRI-IN-3 | C28H23N3O2S | 2763602-67-9 | Details |
| PD184161 | C17H13BrClF2IN2O2 | 212631-67-9 | Details |
| M2N12 | C20H16ClN5O2 | 2376577-06-7 | Details |
| Letolizumab | 1450981-87-9 | Details |
| Zanidatamab | Details |
| Zolbetuximab | 1496553-00-4 | Details |
| Cofetuzumab | 1869928-62-0 | Details |
| M435-1279 | C18H17N3O5S2 | 1359431-16-5 | Details |
| DATP-N3 | C11H17N8O12P3 | 1048021-78-8 | Details |
| AA38-3 | C12H14N2O4 | 65815-76-1 | Details |
| Prezalumab | 1523164-68-2 | Details |
| Vadastuximab | 1436390-63-4 | Details |
| Porgaviximab | 1792982-55-8 | Details |
| Mosunetuzumab | 1905409-39-3 | Details |
| Tiragolumab | 1918185-84-8 | Details |
| Romilkimab | 1399584-78-1 | Details |
| 6-Chloropurine -9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside | C24H18ClFN4O5 | 135473-15-3 | Details |
| N-Desmethyltamoxifen | C25H27NO | 31750-48-8 | Details |
| DUBs-IN-2 | C15H9N5O | 924296-19-5 | Details |
| SP141 | C22H16N2O | 1253491-42-7 | Details |
| Esomeprazole Impurity 3 | C26H30N4O4S | 1346599-85-6 | Details |
| MP07-66 | C19H33NO3 | 1938056-90-6 | Details |
| Crotedumab | 1452387-69-7 | Details |
| Gedivumab | 1807954-17-1 | Details |
| Lacnotuzumab | 1831128-32-5 | Details |
| Tislelizumab | 1858168-59-8 | Details |
| Ladiratuzumab | 1629760-28-6 | Details |
| Netakimab | 1796570-08-5 | Details |
| Paprotrain | C16H11N3 | 57046-73-8 | Details |
| 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-ol | C6H8N2O | 1378606-06-4 | Details |
| PI-273 | C16H16ClN3O2S2 | 925069-34-7 | Details |
| Naratuximab | 1622327-39-2 | Details |
| Suvratoxumab | 1629620-18-3 | Details |
| Tomuzotuximab | 1646321-00-7 | Details |
| Talacotuzumab | 1826831-79-1 | Details |
| Prasinezumab | 1960462-19-4 | Details |
| (3S)-3-(2,2,2-Trifluoroethyl)pyrrolidine | C6H10F3N | 1430091-57-8 | Details |
| SU16f | C24H22N2O3 | 251356-45-3 | Details |
| TC-FPR 43 | C20H21ClN4O2 | 903895-98-7 | Details |
| Selicrelumab | 1622140-49-1 | Details |
| Larcaviximab | 1792982-56-9 | Details |
| Spartalizumab | 1935694-88-4 | Details |
| Iladatuzumab | 1906205-76-2 | Details |
| Ontamalimab | 2098790-40-8 | Details |
| CDK4/6-IN-6 | C22H27ClFN5O3 | 2380321-51-5 | Details |
| WAY-204688 | C34H31F3N2O2 | 796854-35-8 | Details |
| PA 452 | C26H37N3O3 | 457657-34-0 | Details |
| SPP-86 | C16H15N5 | 1357349-91-7 | Details |
| Rivabazumab | 1627519-84-9 | Details |
| Azintuxizumab | 1826819-57-1 | Details |
| Gilvetmab | 1808081-43-7 | Details |
| Ianalumab | 1929549-92-7 | Details |
| Atidortoxumab | 1939108-95-8 | Details |
| Relatlimab | 1673516-98-7 | Details |
| Cusatuzumab | 1399546-01-0 | Details |
| 8-Bromo-3-chloro-5-isopropylisoquinoline | C12H11BrClN | 2660255-85-4 | Details |
| CAY10574 | C9H10N6O | 140651-18-9 | Details |
| Diprotin A | C17H31N3O4 | 90614-48-5 | Details |
| RO-9187 | C9H12N6O5 | 876708-03-1 | Details |
| MRT10 | C24H23N3O5S | 330829-30-6 | Details |
| Sappanone A | C16H12O5 | 102067-84-5 | Details |
| SB-747651A dihydrochloride | C16H23ClN8O | 1781882-72-1 | Details |
| Frunevetmab | 1708936-80-4 | Details |
| Timigutuzumab | 1665274-14-5 | Details |
| Sirtratumab | 1824663-82-2 | Details |
| Bemarituzumab | 1952272-74-0 | Details |
| Tibulizumab | 1849636-24-3 | Details |
| SC-1 | C21H13ClF3N3O2 | 1313019-65-6 | Details |
| Laprituximab | 1622327-38-1 | Details |
| Oleclumab | 1803176-05-7 | Details |
| Mirikizumab | 1884201-71-1 | Details |
| Fenquizone | C14H12ClN3O3S | 20287-37-0 | Details |
| azidamfenicol | C11H13N5O5 | 13838-08-9 | Details |
| GLUT inhibitor-1 | C32H35N7O2 | 2421141-40-2 | Details |
| EN523 | C12H14N2O3 | 2094893-05-5 | Details |
| GSK 2256294A | C21H24F3N7O | 1142090-23-0 | Details |
| 4'-C-Fluoro-uridine | C9H11FN2O6 | 1613589-24-4 | Details |
| Navicixizumab | 1638338-43-8 | Details |
| Cosfroviximab | 1792982-57-0 | Details |
| Loncastuximab | 1875032-68-0 | Details |
| Berlimatoxumab | 1939109-24-6 | Details |
| Crovalimab | 1917321-26-6 | Details |
| Faricimab | 1607793-29-2 | Details |
| CJ033466 | C19H28ClN5O | 519148-48-2 | Details |
| Lesofavumab | 1807960-57-1 | Details |
| Gatipotuzumab | 1264737-26-9 | Details |
| Gimsilumab | 1648796-29-5 | Details |
| Zenocutuzumab | 1969309-56-5 | Details |
| SR 13800 | C25H29N3O2S | 227321-12-2 | Details |
| STAT5-IN-2 | C26H27N3O | 2111834-61-6 | Details |
| NLG802 | C20H30ClN3O3 | 2071683-99-1 | Details |
| Tafluprost Impurity 16Z | Details |
| MAO-B-IN-2 | C18H11ClO3 | 1253978-24-3 | Details |
| 2-Oxa-6,9-diazaspiro[4.5]decane-6-carboxylic acid, 1,1-dimethylethyl ester | C12H22N2O3 | 1784402-13-6 | Details |
| SB-747651A | C16H22N8O | 607372-46-3 | Details |
| M-525 | C39H51FN6O5S | 2173582-08-4 | Details |
| SBP3264 | Details |
| SGK1-IN-4 | C23H21ClFN5O4S | 1628048-93-0 | Details |
| MRT-81 | C31H29N3O5S | 1263132-08-6 | Details |
| ML328 | C22H21F3N6O3S | 634175-34-1 | Details |
| Product Total： Product Page： | ||||
| 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||